Alogliptin Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.7 Antidiabetics18.7.2 Oral hypoglycemics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Alogliptin Manufacturers of Alogliptin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Alogliptin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 6.25 mg6.2 (6.25)As recommended.POfor patients with severe renal impairment12.5 mg12 (12.5)As recommended.POfor patient for moderate renal impairment25 mg25 (25)As recommended.POCan be taken with or without food Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Alogliptin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Alogliptin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Alogliptin Back to top Manufacturers of Alogliptin in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Alogliptin Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.7 Antidiabetics18.7.2 Oral hypoglycemics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Alogliptin Manufacturers of Alogliptin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Alogliptin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 6.25 mg6.2 (6.25)As recommended.POfor patients with severe renal impairment12.5 mg12 (12.5)As recommended.POfor patient for moderate renal impairment25 mg25 (25)As recommended.POCan be taken with or without food Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Alogliptin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Alogliptin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Alogliptin Back to top Manufacturers of Alogliptin in Pakistan Back to top Previous Drug Generic - Next Drug Generic